Stevanato Group’s Post

#InvestorNews: #EYPT to report Q4 2023 financial results and recent corporate developments at our upcoming webcast. Learn more below:

Tomorrow, we will announce our financial results for the 3rd quarter of 2023. All details in a nutshell: ➡️ 7 a.m. (CET): Publication of our Q3 results ➡️ 9:30 a.m. (CET): Media conference call ➡️ 2 p.m. (CET): Conference call for analysts You can find further information here: https://lnkd.in/eRmPRD-g #EMDresults #Q3 #FinancialResults

Q3 2024 Financial Results are In

Here’s Where the Financial Support For The Campaign Behind Ohio’s Issue 2 Is Coming From

What are the price targets NOW for Alpha Tau Medical, NASDAQ-DRTS? The price targets for Alpha Tau Medical (DRTS) stock vary based on analysts’ predictions. Here’s a summary: The consensus rating for DRTS is Buy, based on the current 4 buy ratings from analysts in the last year. The average twelve-month price prediction for Alpha Tau Medical is $12.00. The high price target is $23.00, while the low price target is $8.0012. Keep in mind that these forecasts are subject to change based on market dynamics and company performance. Always consult the most up-to-date information when making investment decisions. 📈🔍 Learn more 1 marketbeat.com2 zacks.com3 wallstreetzen.com4 benzinga.com

Roivant to Report Financial Results for the First Quarter

This an excellent analysis.

Immediate access to key insights derived from vast market data is crucial for achieving brand and portfolio success. Join this webinar to discover a unique partnership model that blends expertise, processes, and technology to scale that will accelerate market-readycommercial analytics. https://bit.ly/47UKgVa #CommercialAnalytics #Pharma #advancedanalytics #commercialsuccess

#EYPT reports Q1 2024 financial results and recent corporate developments. Learn more below.

As Total Market Solutions' article demonstrates, in its focus on OCT, “the commercial reward may be very great for investors prepared to stay the course through the regulatory and financial challenges the company will have to negotiate”. Read more below ⬇️ https://lnkd.in/dnQzSnsU